Device Trial Radar · NCT02862262
A Multi-Site Clinical Evaluation of the ARIES Bordetella Assay in Symptomatic Patients
Last checked: Nov 20, 2026Latest source record: Oct 4, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,052
Actual
Start
Jul 2016
Primary completion
Nov 2016
Study completion Nov 14, 2016
Sponsor
- Lead sponsor
- Luminex Molecular DiagnosticsNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 11, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A three-arm, multi-site clinical evaluation of the ARIES Bordetella Assay for the detection and identification of Bordetella pertussis (B. pertussis) and Bordetella parapertussis (B. parapertussis) nucleic acids in prospectively collected, de-identified, left-over clinical specimens; banked, pre-selected clinical specimens; and contrived specimens.
Conditions
- Bordetella Infections
- Bordetella Pertussis Infection
- Bordetella Parapertussis Infection
Interventions
ARIES Bordetella AssayDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Specificity and sensitivity of the ARIES Bordetella Assay in patients suspected of having respiratory infection attributable to B. pertussis or B. parapertussis.Time frame: 5 months
Locations
6 sites in 2 countries. Site status is shown where the registry gives one.
Indiana University Health
Indianapolis, Indiana
5 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.